Understanding the Amyloid Hypothesis in Alzheimer's Disease
- PMID: 30883346
- DOI: 10.3233/JAD-180802
Understanding the Amyloid Hypothesis in Alzheimer's Disease
Abstract
The amyloid hypothesis (AH) is still the most accepted model to explain the pathogenesis of inherited Alzheimer's disease (IAD). However, despite the neuropathological overlapping with the non-inherited form (NIAD), AH waver in explaining NIAD. Thus, 30 years after its first statement several questions are still open, mainly regarding the role of amyloid plaques (AP) and apolipoprotein E (APOE). Accordingly, a pathogenetic model including the role of AP and APOE unifying IAD and NIAD pathogenesis is still missing. In the present understanding of the AH, we suggested that amyloid-β (Aβ) peptides production and AP formation is a physiological aging process resulting from a systemic age-related decrease in the efficiency of the proteins catabolism/clearance machinery. In this pathogenetic model Aβ peptides act as neurotoxic molecules, but only above a critical concentration [Aβ]c. A threshold mechanism triggers IAD/NIAD onset only when [Aβ]≥[Aβ]c. In this process, APOE modifies [Aβ]c threshold in an isoform-specific way. Consequently, all factors influencing Aβ anabolism, such as amyloid beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) gene mutations, and/or Aβ catabolism/clearance could contribute to exceed the threshold [Aβ]c, being characteristic of each individual. In this model, AP formation does not depend on [Aβ]c. The present interpretation of the AH, unifying the pathogenetic theories for IAD and NIAD, will explain why AP and APOE4 may be observed in healthy aging and why they are not the cause of AD. It is clear that further studies are needed to confirm our pathogenetic model. Nevertheless, our suggestion may be useful to better understand the pathogenesis of AD.
Keywords: Alpha-secretase; Alzheimer’s disease; amyloid hypothesis; amyloid plaque; amyloid precursor protein; amyloid-alpha peptide; amyloid-beta peptide; apolipoprotein E; beta-secretase; inherited Alzheimer’s disease; non-inherited Alzheimer’s disease.
Similar articles
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.Acta Neuropathol Commun. 2015 Nov 10;3:70. doi: 10.1186/s40478-015-0250-y. Acta Neuropathol Commun. 2015. PMID: 26556230 Free PMC article.
-
The interaction of amyloid-beta with ApoE.Subcell Biochem. 2005;38:255-72. doi: 10.1007/0-387-23226-5_13. Subcell Biochem. 2005. PMID: 15709483 Review.
-
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543533 Free PMC article.
-
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.J Neurosci. 2005 Mar 16;25(11):2803-10. doi: 10.1523/JNEUROSCI.5170-04.2005. J Neurosci. 2005. PMID: 15772340 Free PMC article.
Cited by
-
The complex effects of miR-146a in the pathogenesis of Alzheimer's disease.Neural Regen Res. 2025 May 1;20(5):1309-1323. doi: 10.4103/NRR.NRR-D-23-01566. Epub 2024 Jun 3. Neural Regen Res. 2025. PMID: 39075895 Free PMC article.
-
Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis.Hum Mol Genet. 2025 Apr 6;34(8):739-748. doi: 10.1093/hmg/ddaf017. Hum Mol Genet. 2025. PMID: 39927718
-
Adult hippocampal neurogenesis and its impairment in Alzheimer's disease.Zool Res. 2022 May 18;43(3):481-496. doi: 10.24272/j.issn.2095-8137.2021.479. Zool Res. 2022. PMID: 35503338 Free PMC article. Review.
-
Imbalance of Essential Metals in Traumatic Brain Injury and Its Possible Link with Disorders of Consciousness.Int J Mol Sci. 2023 Apr 6;24(7):6867. doi: 10.3390/ijms24076867. Int J Mol Sci. 2023. PMID: 37047843 Free PMC article. Review.
-
Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study.Pharmacoeconomics. 2025 Feb;43(2):153-169. doi: 10.1007/s40273-024-01443-2. Epub 2024 Nov 1. Pharmacoeconomics. 2025. PMID: 39485581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous